Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Victory Park Special Situations Master Fund, Ltd.
  2. Issuer Name and Ticker or Trading Symbol
GLOBAL MED TECHNOLOGIES INC [GLOB]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O WALKERS SPV LIMITED, WALKER HOUSE, 87 MARY STREET, GEORGE TOWN
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2010
(Street)

GRAND CAYMAN, CAYMAN ISLANDS,  KY1 9002
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/25/2010   U   4,876,765 (1) D $ 1.22 0 D (2)  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $ 0.72 03/25/2010   J(3)     4,125,000 (3)   (4) 12/16/2010 Common Stock 4,125,000 (3) $ 0.5 0 D (2)  
Series A Convertible Preferred Stock $ 0.72 03/25/2010   U     5,500,000 (1)   (4)   (4) Common Stock 5,500,000 (1) $ 1,694.44 0 D (2)  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Victory Park Special Situations Master Fund, Ltd.
C/O WALKERS SPV LIMITED, WALKER HOUSE
87 MARY STREET, GEORGE TOWN
GRAND CAYMAN, CAYMAN ISLANDS KY1 9002
    X    
Jacob Capital, L.L.C.
227 W. MONROE STREET, SUITE 3900
CHICAGO, IL 60606
    X    
Victory Park Capital Advisors, LLC
227 W. MONROE STREET, SUITE 3900
CHICAGO, IL 60606
    X    
Levy Richard N
227 W. MONROE STREET, SUITE 3900
CHICAGO, IL 60606
    X    

Signatures

 /s/ Richard Levy, Victory Park Special Situations Master Fund, Ltd., Attorney-in-fact   03/25/2010
**Signature of Reporting Person Date

 /s/ Richard Levy, Jacob Capital, L.L.C., Sole Member   03/25/2010
**Signature of Reporting Person Date

 /s/ Richard Levy, Victory Park Capital Advisors, LLC, Jacob Capital, L.L.C., Manager, Sole Member   03/25/2010
**Signature of Reporting Person Date

 /s/ Richard Levy   03/25/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Reporting Persons tendered these shares to Atlas Acquisition Corp. ("Purchaser") pursuant to Purchaser's offer (the "Tender Offer") to purchase all of the outstanding shares of Global Med Technologies, Inc. common stock ("Common Stock") at a cash purchase price of $1.22 per share, and series A convertible preferred stock ("Preferred Stock") at a cash price of $1,694.44 per share, subject to the terms described in the Offer to Purchase, filed with the Securities and Exchange Commission on February 19, 2010, and the Agreement and Plan of Merger, dated as of January 31, 2010, by and among Haemonetics Corporation, Purchaser, and Global Med Technologies, Inc. The Common Stock and Preferred Stock was purchased by Purchaser in the Tender Offer on March 25, 2010.
(2) The reported securities are owned directly by Victory Park Special Situations Master Fund Ltd. (the "Fund") and indirectly by (i) Victory Park Capital Advisors, LLC as the investment manager for the Fund, (ii) Jacob Capital, L.L.C., as the manager of Victory Park Capital Advisors, LLC and (iii) Richard Levy, as the sole member of Jacob Capital, L.L.C.
(3) In connection with the Tender Offer described in Footnote 1, the Warrant was disposed of and terminated effective immediately prior to the expiration of the Tender Offer in exchange for the right to receive a lump sum cash payment (without interest), less any applicable withholding taxes, equal to the product of (i) the excess of $1.22 per share over the per share exercise price for the Warrant and (ii) the number of shares subject to the Warrant.
(4) The Warrant and the Preferred Stock were subject to so-called "blocker" provisions prohibiting the holder from exercising the Warrant or converting the Preferred Stock, as applicable, to the extent that such exercise or conversion would result in the holder becoming the beneficial owner of more than 9.99% of the outstanding Common Shares. The Preferred Stock had no expiration date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.